In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

In fact, the three bivariate Cox regression analysis with TNFRSF4 and the three clinical variables already mentioned have different behaviors: when including MYCN amp/no-amp, the model does not retain the TNFRSF4 variable although it is close to significance (p=0.083).

also in 2,130 other papers